BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 18519164)

  • 1. Synthesis and biological activities of reveromycin A and spirofungin A derivatives.
    Shimizu T; Usui T; Fujikura M; Kawatani M; Satoh T; Machida K; Kanoh N; Woo JT; Osada H; Sodeoka M
    Bioorg Med Chem Lett; 2008 Jul; 18(13):3756-60. PubMed ID: 18519164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemical modification of reveromycin A and its biological activities.
    Shimizu T; Usui T; Machida K; Furuya K; Osada H; Nakata T
    Bioorg Med Chem Lett; 2002 Dec; 12(23):3363-6. PubMed ID: 12419362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spirofungin A: stereoselective synthesis and inhibition of isoleucyl-tRNA synthetase.
    Marjanovic J; Kozmin SA
    Angew Chem Int Ed Engl; 2007; 46(46):8854-7. PubMed ID: 17929337
    [No Abstract]   [Full Text] [Related]  

  • 4. Asymmetric total synthesis of (-)-spirofungin A and (+)-spirofungin B.
    Shimizu T; Satoh T; Murakoshi K; Sodeoka M
    Org Lett; 2005 Dec; 7(25):5573-6. PubMed ID: 16320994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reveromycin A, an agent for osteoporosis, inhibits bone resorption by inducing apoptosis specifically in osteoclasts.
    Woo JT; Kawatani M; Kato M; Shinki T; Yonezawa T; Kanoh N; Nakagawa H; Takami M; Lee KH; Stern PH; Nagai K; Osada H
    Proc Natl Acad Sci U S A; 2006 Mar; 103(12):4729-34. PubMed ID: 16537392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-function analyses of cytochrome P450revI involved in reveromycin A biosynthesis and evaluation of the biological activity of its substrate, reveromycin T.
    Takahashi S; Nagano S; Nogawa T; Kanoh N; Uramoto M; Kawatani M; Shimizu T; Miyazawa T; Shiro Y; Osada H
    J Biol Chem; 2014 Nov; 289(47):32446-58. PubMed ID: 25258320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Total synthesis of (-)-reveromycin a.
    El Sous M; Ganame D; Tregloan PA; Rizzacasa MA
    Org Lett; 2004 Aug; 6(17):3001-4. PubMed ID: 15330668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Total synthesis of reveromycin A.
    Shimizu T; Masuda T; Hiramoto K; Nakata T
    Org Lett; 2000 Jul; 2(14):2153-6. PubMed ID: 10891254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enantioselective synthesis of the [6,6] spiroketal core of reveromycin A.
    Drouet KE; Ling T; Tran HV; Theodorakis EA
    Org Lett; 2000 Jan; 2(2):207-10. PubMed ID: 10814283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereoselective total synthesis of (-)-spirofungin A by utilising hydrogen-bond controlled spiroketalisation.
    Lynch JE; Zanatta SD; White JM; Rizzacasa MA
    Chemistry; 2011 Jan; 17(1):297-304. PubMed ID: 21207625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reveromycins revealed: new polyketide spiroketals from Australian marine-derived and terrestrial Streptomyces spp. A case of natural products vs. artifacts.
    Fremlin L; Farrugia M; Piggott AM; Khalil Z; Lacey E; Capon RJ
    Org Biomol Chem; 2011 Feb; 9(4):1201-11. PubMed ID: 21152660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Total synthesis of the proposed structure for spirofungin B: a reassignment of the stereochemistry.
    Zanatta SD; White JM; Rizzacasa MA
    Org Lett; 2004 Mar; 6(6):1041-4. PubMed ID: 15012095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and biological activity of enantiomeric pairs of 5-[(E)-cycloalk-2-enylidenemethyl]thiolactomycin congeners.
    Ohata K; Terashima S
    Bioorg Med Chem Lett; 2008 Oct; 18(20):5598-600. PubMed ID: 18805004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of the spirofungin B core by a reductive cyclization strategy.
    La Cruz TE; Rychnovsky SD
    Org Lett; 2005 Apr; 7(9):1873-5. PubMed ID: 15844928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory mechanism of reveromycin A at the tRNA binding site of a class I synthetase.
    Chen B; Luo S; Zhang S; Ju Y; Gu Q; Xu J; Yang XL; Zhou H
    Nat Commun; 2021 Mar; 12(1):1616. PubMed ID: 33712620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reveromycin A, a new antibiotic which inhibits the mitogenic activity of epidermal growth factor.
    Osada H; Koshino H; Isono K; Takahashi H; Kawanishi G
    J Antibiot (Tokyo); 1991 Feb; 44(2):259-61. PubMed ID: 2010365
    [No Abstract]   [Full Text] [Related]  

  • 17. Stereoselective total synthesis of reveromycin B and C19-epi-reveromycin B.
    Drouet KE; Theodorakis EA
    Chemistry; 2000 Jun; 6(11):1987-2001. PubMed ID: 10894398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short synthesis of the 6,6-spiroketal cores of spirofungins A and B.
    Dias LC; de Oliveira LG
    Org Lett; 2004 Jul; 6(15):2587-90. PubMed ID: 15255697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Total synthesis of reveromycin B.
    Masuda T; Osako K; Shimizu T; Nakata T
    Org Lett; 1999 Sep; 1(6):941-4. PubMed ID: 10823225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spiro-piperidine azetidinones as potent TRPV1 antagonists.
    Xiao D; Palani A; Aslanian R; McKittrick BA; McPhail AT; Correll CC; Phelps PT; Anthes JC; Rindgen D
    Bioorg Med Chem Lett; 2009 Feb; 19(3):783-7. PubMed ID: 19114307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.